Abstract
The COVID-19 pandemic brought not only global devastation but also an unprecendented infodemic of false or misleading information that spread rapidly through online social networks. Network analysis plays a crucial role in the science of fact-checking by modeling and learning the risk of infodemics through statistical processes and computation on mega-sized graphs. This paper proposes MEGA, Machine Learning-Enhanced Graph Analytics, which uses a combination of feature engineering and graph neural networks to enhance the efficiency of learning performance and parallel computation involving massive graphs. Infodemic risk analysis is a unique application of the MEGA framework, which involves detecting spambots by counting triangle motifs and identifying influential spreaders by computing the distance center. The MEGA framework is evaluated using the COVID-19 Infodemic Twitter dataset, demonstrating superior computational efficiency and classification accuracy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
(e-mail: {cnhang3-c{at}my.cityu.edu.hk, siyachen4-c{at}my.cityu.edu.hk}).
(e-mail: peiduoyu{at}cycu.edu.tw).
(e-mail: cheewei.tan{at}ntu.edu.sg).
(e-mail: eegchen{at}cityu.edu.hk).
Title updated Author list updated Author affiliations updated Supplemental files updated
Data Availability
No
